Clinical Trial Update: Safety and Efficacy Study of the Hydrus Aqueous Implant in Subjects With POAG [Phase 1, Phase 2]

View source ↗

Summary

The Hydrus Aqueous Implant safety and efficacy study for primary open-angle glaucoma (Phase 1/2) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Hydrus Aqueous Implant

Snippet

Sponsor: Ivantis, Inc. | Conditions: Primary Open Angle Glaucoma | Phase 1, Phase 2 | Status: COMPLETED